Recombinant Laminin E8 Fragment for Feeder-Free Stem Cell Culture
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for maintaining human pluripotent stem cells in a pluripotent state require feeder cells or xenogeneic components, which are restrictive for clinical applications and unsatisfactory in terms of quality and safety.
Innovation Solution
A culture substrate coated with human laminin α5β1γ1 E8 fragment or human laminin α3β3γ2 E8 fragment, allowing for feeder-free and xeno-free culture conditions, enabling the maintenance of human pluripotent stem cells in a pluripotent state.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If Matrigel is used as an extracellular matrix for human pluripotent stem cell culture, then maintenance of pluripotency is highly effective, but the use of xenogeneic components restricts clinical application
Solution Approach 1:
The invention segments the laminin molecule by using a specific fragment (E8 fragment corresponding to residues 884-1154 from the C-terminus of the γ1 chain) instead of the full-length laminin or complex mixtures like Matrigel. This segmentation provides a defined, homogeneous protein structure that maintains pluripotency while eliminating xenogeneic impurities, directly resolving the contradiction between effectiveness and safety
Solution Approach 2:
The invention changes the molecular weight parameter from the full-length laminin (800,000 Da) to a truncated fragment (approximately 90,000 Da). This parameter change maintains the critical integrin-binding function while improving solubility, reducing immunogenicity, and enabling recombinant production, thus resolving the contradiction between maintaining pluripotency and eliminating xenogeneic components
2Object-affected harmful factors
If human vitronectin or human fibronectin is used as a human extracellular matrix, then xeno-free conditions are achieved, but attachment efficiency and maintenance of undifferentiated state are inferior to Matrigel
Solution Approach 1:
The invention changes the molecular structure parameter by using a laminin fragment with specific integrin-binding domains rather than full-length laminin or alternative proteins like vitronectin or fibronectin. This parameter change optimizes the balance between attachment efficiency and pluripotency maintenance, achieving superior results to existing human-derived matrices while maintaining xeno-free conditions
Solution Approach 2:
The invention uses a composite approach by combining specific laminin fragments (α5β1γ1 E8 fragment or α3β3γ2 E8 fragment) to create a recombinant human laminin product. This composite human-derived matrix replaces xenogeneic Matrigel while maintaining the necessary biochemical functions for pluripotency maintenance, resolving the contradiction between safety and effectiveness
3Reliability
If full-length laminin is used as a culture substrate, then integrin binding activity is achieved, but the large molecular weight makes recombinant expression difficult and yield is low
Solution Approach 1:
The invention segments the large laminin molecule (800,000 Da) into a smaller E8 fragment (approximately 90,000 Da) that retains the critical integrin-binding function. This segmentation dramatically improves recombinant expression ease and yield while maintaining the necessary biological activity, directly resolving the contradiction between functionality and manufacturability
Solution Approach 2:
The invention extracts only the essential E8 fragment (residues 884-1154 from the C-terminus of the γ1 chain) that contains the integrin-binding domain, discarding the rest of the large laminin structure. This extraction maintains the critical adhesion function while enabling efficient recombinant production, resolving the contradiction between integrin binding activity and ease of manufacture
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The culture substrate supports rapid expansion and proliferation of human pluripotent stem cells, facilitates the separation of single-cell-derived clones, and provides a safe and homogeneous culture environment, overcoming the limitations of existing extracellular matrices.
Implementation Method 1
Laminin is a major cell-adhesion protein present in the basement membrane. The present inventors examined the type of integrins expressed on human ES cells, and reported that α6β1 integrin is a major adhesion receptor of human ES cells and that recombinant human laminins (particularly, laminin 332 composed of α3, β3 and γ2 chains, and laminin 511 composed of α5, β1 and γ1 chains) are effective for maintaining the pluripotency of human ES cells
Data Source
Figure 1
Figure 2
Figure 3
AI summary
The present invention provides a culture substrate which enables maintenance culture of human pluripotent stem cells in a pluripotent state under a feeder-free culture environment, and a culture method of human pluripotent stem cells using the culture substrate. By seeding human pluripotent stem cells dissociated into single cells at a cell density of 4×104 to 10×104 cells/cm2 onto a culture substrate coated with human laminin α5β1γ1 E8 fragment or human laminin α3β3γ2 E8 fragment preferably at a concentration of 0.5 to 25 µg/cm2, the human pluripotent stem cells can be rapidly expanded in a pluripotent state.